Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy

Aim of investigation. To outline predictive model for unfavorable course of ulcerative colitis (UC).Material and methods. Overall 232 patients with UC were included in original study, 84 of them had favourable and 148 – unfavorable course of disease.Results. Prognostic system for various variants of...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Yu. Baranovsky, E. A. Kondrashina, A. G. Kharitonov
Format: Article
Language:Russian
Published: Gastro LLC 2012-06-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/1301
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860240442982400
author A. Yu. Baranovsky
E. A. Kondrashina
A. G. Kharitonov
author_facet A. Yu. Baranovsky
E. A. Kondrashina
A. G. Kharitonov
author_sort A. Yu. Baranovsky
collection DOAJ
description Aim of investigation. To outline predictive model for unfavorable course of ulcerative colitis (UC).Material and methods. Overall 232 patients with UC were included in original study, 84 of them had favourable and 148 – unfavorable course of disease.Results. Prognostic system for various variants of course of UC and its complications, 27 most significant clinical signs of disease based on differentiated clinical and statistical evaluation was submitted. To define indications for «top down» therapy with application of TNF-α blockers clinically approved algorithm of prognostic decisions for development of favorable (uncomplicated, rarely relapsing) and unfavorable (frequently relapsing, continuous, steroiddependent) variants of disease, and its complications was stated. Basing on high scores of sensitivity (accuracy) and specificity of prognosis, that were received, data proving potential of indications for early anticytokine treat­ment by infliximab to avoid unfavorable course and complications of ulcerative colitis are presented.
format Article
id doaj-art-e16325ba2cb44edf8f031bc14ca4b44b
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2012-06-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-e16325ba2cb44edf8f031bc14ca4b44b2025-02-10T16:14:32ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732012-06-012236369873Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapyA. Yu. Baranovsky0E. A. Kondrashina1A. G. Kharitonov2State educational government-financed institution of higher professional education Mechnikov North-Western State medical UniversityState educational government-financed institution of higher professional education Mechnikov North-Western State medical UniversityState educational government-financed institution of higher professional education Mechnikov North-Western State medical UniversityAim of investigation. To outline predictive model for unfavorable course of ulcerative colitis (UC).Material and methods. Overall 232 patients with UC were included in original study, 84 of them had favourable and 148 – unfavorable course of disease.Results. Prognostic system for various variants of course of UC and its complications, 27 most significant clinical signs of disease based on differentiated clinical and statistical evaluation was submitted. To define indications for «top down» therapy with application of TNF-α blockers clinically approved algorithm of prognostic decisions for development of favorable (uncomplicated, rarely relapsing) and unfavorable (frequently relapsing, continuous, steroiddependent) variants of disease, and its complications was stated. Basing on high scores of sensitivity (accuracy) and specificity of prognosis, that were received, data proving potential of indications for early anticytokine treat­ment by infliximab to avoid unfavorable course and complications of ulcerative colitis are presented.https://www.gastro-j.ru/jour/article/view/1301ulcerative colitisprognosisanticytokine therapy
spellingShingle A. Yu. Baranovsky
E. A. Kondrashina
A. G. Kharitonov
Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
ulcerative colitis
prognosis
anticytokine therapy
title Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
title_full Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
title_fullStr Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
title_full_unstemmed Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
title_short Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
title_sort prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
topic ulcerative colitis
prognosis
anticytokine therapy
url https://www.gastro-j.ru/jour/article/view/1301
work_keys_str_mv AT ayubaranovsky prognosisofunfavorablecourseofulcerativecolitisasindicationforanticytokinetherapy
AT eakondrashina prognosisofunfavorablecourseofulcerativecolitisasindicationforanticytokinetherapy
AT agkharitonov prognosisofunfavorablecourseofulcerativecolitisasindicationforanticytokinetherapy